Comparison Marker Therapeutics (MRKR) with Competitors
Marker Therapeutics (MRKR) industry is Biotechnology.
Operating Margin
MRKR-338.50%
Industry-2055.25%
Upside+1716.75%
Free Cash Flow Yield
MRKR-33.63%
Industry-1.75%
Upside-31.88%
P/E
MRKR-1.84
Industry-20.52
Upside+1867.99%
P/S
MRKR6.63
Industry10.01
Upside-33.79%
P/B
MRKR1.75
Industry5.15
Upside-66.08%